Does Tysabri SC have a patent?
Tysabri (natalizumab) is an established biologic, and any “Tysabri SC” (subcutaneous) product would typically be covered by patents on aspects such as the formulation, delivery method, device, dosing regimen, and method-of-use—separately from patents that cover the underlying biologic molecule.
However, whether there is a specific active patent for “Tysabri SC” specifically cannot be determined from the information provided here. Patent status depends on the exact product name, the country, the applicant/assignee, and whether you mean patents for natalizumab itself or patents unique to the subcutaneous presentation.
What kinds of patents would cover a subcutaneous Tysabri version?
If a subcutaneous version exists, patent coverage commonly includes:
- The subcutaneous formulation (e.g., excipients and concentration) [1]
- The injection method or administration device (e.g., autoinjector/pen) [1]
- Methods of treating diseases with that subcutaneous route and dosing schedule [1]
- Manufacturing or process patents for the formulation [1]
How can I check whether there’s an active patent for “Tysabri SC”?
To answer this precisely, you usually need to look up patents by:
- The exact “Tysabri SC” trade name used in your country (or the generic/substance name used for the filing)
- The manufacturer/assignee (likely the drug’s owner)
- The jurisdiction (US, EP, UK, etc.)
- The patent family and expiration dates
If you tell me the country you care about (e.g., US or EU) and the exact labeling for “Tysabri SC” (or the manufacturer), I can help you narrow down what to search for and how to interpret the results.
Does patent status differ by region?
Yes. A biologic’s patent estate and exclusivity rules vary by jurisdiction, and different filings can expire at different times. Even when the active ingredient is old, a newer delivery route (subcutaneous vs IV) can have separate, later-dated patent coverage [1].
---
Sources
[1] World Intellectual Property Organization (WIPO), general background on how patents are filed and how coverage can differ by invention type and jurisdiction: https://www.wipo.int/patents/en/